Dr. Lindsay Figg is a pharmacist who is specialized in Oncology in Louisville, Kentucky. Patients can reach her at 529 S Jackson St, Louisville or contact her on 412-977-9939. Active license number of Dr. Lindsay Figg is 015795 for Oncology in Kentucky. Dr. Lindsay Figg is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Lindsay Figg speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Lindsay Figg
Specialization:
Oncology
Credentials:
PHARMD, BCOP
Gender:
Female
Location:
529 S Jackson St, Louisville, Kentucky, 40202-3229
Phone:
412-977-9939
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Lindsay Figg are as mentioned below.
NPI Number:
1336866250
NPI Enumeration Date:
21 Oct, 2022
NPI Last Update On:
21 Oct, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Lindsay Figg are as mentioned below.
Specialization
License Number
State
Status
Oncology
015795
Kentucky
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
529 S Jackson Street, Bcc Pharmacy, 2nd Floor Louisville, Kentucky
Zip:
40202-3229
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Lindsay Figg at 529 S Jackson St, Louisville, Kentucky or can call on phone at 412-977-9939.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.